Patents by Inventor Tina Bjeldskov Pedersen

Tina Bjeldskov Pedersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20230364241
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: December 9, 2022
    Publication date: November 16, 2023
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20200316204
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: June 24, 2020
    Publication date: October 8, 2020
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Propylene Glycol-Containing Peptide Formulations which are Optimal for Production and for Use in Injection Devices
    Publication number: 20190231876
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: January 29, 2019
    Publication date: August 1, 2019
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
    Publication number: 20120225810
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Application
    Filed: January 31, 2012
    Publication date: September 6, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
    Patent number: 8114833
    Abstract: The present invention relates to pharmaceutical formulations comprising a peptide and propylene glycol, to methods of preparing such formulations, and to uses of such formulations in the treatment of diseases and conditions for which use of the peptide contained in such formulations is indicated. The present invention further relates to methods for reducing the clogging of injection devices by a peptide formulation and for reducing deposits on production equipment during production of a peptide formulation.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: February 14, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Tina Bjeldskov Pedersen, Claude Bonde, Dorthe Kot Engelund
  • Stable pharmaceutical compositions
    Patent number: 7595293
    Abstract: Pharmaceutical composition for parenteral administration comprising a glucagon-like peptide and human serum albumin or a variant thereof.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: September 29, 2009
    Assignee: Novo Nordisk A/S
    Inventors: Dorthe Kot Engelund, Tina Bjeldskov Pedersen, Claude Bonde